The role of Card9 overexpression in peripheral blood mononuclear cells from patients with aseptic acute pancreatitis

Zhi‐wen Yang, Chengzhao Weng, Jing Wang, Ping XuJournal of Cellular and Molecular Medicine 2015 · DOI

TL;DR

This study investigates the role of Card9, a protein involved in immune responses, in aseptic acute pancreatitis (SAP). Researchers found that Card9 is significantly overexpressed in the peripheral blood mononuclear cells (PBMCs) of SAP patients, particularly in the early stages, and this overexpression correlates with disease severity. This suggests Card9 may be a potential biomarker and therapeutic target for non-infectious inflammation in SAP.

What Problem Does This Paper Address?

Severe acute pancreatitis (SAP) is a life-threatening condition with high mortality, and its early molecular mechanisms are not fully understood. Activated mononuclear cells are known to play a crucial role in the inflammatory cascade that leads to SAP. However, the specific molecular triggers for this activation, especially in cases without bacterial or fungal infection (aseptic SAP), remain unclear. This paper aims to elucidate the potential role of Card9, an adaptor protein primarily found in monocytes and macrophages, in the early stages of aseptic SAP. Understanding this could lead to better diagnostic tools and therapeutic strategies.

Methods

The researchers employed a multi-pronged approach to investigate Card9's role:

  • Patient Cohort and Sample Collection: Data was collected from 72 subjects, including patients with mild acute pancreatitis (MAP), severe acute pancreatitis (SAP), and healthy volunteers. PBMCs were isolated from SAP and MAP patients on days 1, 3, and 5 after symptom onset, while healthy volunteers provided single samples. Crucially, microbial cultures were performed to confirm the aseptic nature of the pancreatitis in the studied patients.
  • Card9 Expression Analysis:
    • Immunofluorescence Staining: Used to visualize and quantify Card9 protein expression in PBMCs, allowing for direct comparison between groups and over time.
  • Quantitative Real-time PCR (qRT-PCR): Employed to measure Card9 mRNA levels, providing insight into gene expression.
  • Western Blotting: Used to detect and quantify Card9 protein levels, confirming findings from immunofluorescence.
  • Signaling Pathway Investigation:
    • Western Blotting: Also used to assess the activation of key inflammatory signaling pathways, specifically NF-κB (p65 subunit) and p38 MAPK, in PBMCs.
  • Immunoprecipitation: Utilized to investigate the formation of a Card9-Bcl10 complex, a known signaling intermediate.
  • Cytokine Measurement: ELISA kits were used to measure the levels of pro-inflammatory cytokines (IL-17, IL-1β, IL-6, and TNF-α) in serum.
  • Statistical Analysis: Standard statistical methods, including t-tests, Mann-Whitney U-tests, Spearman's rank tests, and Receiver Operating Characteristic (ROC) curve analysis, were used to analyze the data and assess diagnostic value.

Datasets

The study utilized data from a cohort of 72 human subjects:

  • 35 patients with Mild Acute Pancreatitis (MAP)
  • 17 patients with Severe Acute Pancreatitis (SAP)
  • 20 healthy volunteers (Control group)

PBMCs were collected from these individuals at specific time points (day 1, 3, and 5 post-symptom onset for patients). Serum samples were also collected. No new benchmark datasets were introduced; the study relied on clinical data and biological samples from human participants.

Key Insights and Ideas

  • Card9 is a Key Player in Aseptic SAP: The most significant finding is the clear overexpression of Card9 in PBMCs of SAP patients, even in the absence of microbial infection. This challenges the traditional view of Card9's primary role being solely in fighting infections.
  • Card9's Role in Non-Infectious Inflammation: This study strongly suggests that Card9 is involved in the inflammatory cascade of aseptic SAP, potentially by recognizing endogenous danger signals rather than exogenous pathogens.
  • Card9 as a Biomarker: The ROC curve analysis indicates that Card9 levels in PBMCs have a good sensitivity and specificity for predicting SAP, suggesting its potential as a diagnostic or prognostic marker.
  • Card9-Mediated Signaling: The research provides evidence that Card9 overexpression in SAP is linked to the activation of NF-κB and p38 MAPK pathways, which are critical in inflammatory responses. The formation of a Card9-Bcl10 complex further supports this signaling role.
  • Cytokine Dysregulation: The study links Card9 activation to increased levels of key pro-inflammatory cytokines like IL-17, IL-1β, IL-6, and TNF-α, which are known drivers of SAP pathology.

Key Results

  • Card9 Overexpression: Card9 expression in PBMCs was significantly higher in SAP patients compared to MAP patients and healthy controls, peaking on day 1 of pancreatitis.
  • Cytokine Levels: Pro-inflammatory cytokines (IL-17, IL-1β, IL-6, TNF-α) were significantly elevated in SAP patients, correlating with Card9 levels.
  • NF-κB and p38 Activation: Western blot analysis showed increased levels of activated NF-κB (p65) and p38 MAPK in PBMCs from SAP patients compared to MAP and control groups.
  • Card9-Bcl10 Complex: Inducible formation of the Card9-Bcl10 complex was observed in PBMCs from SAP patients.
  • Diagnostic Potential: ROC curve analysis showed Card9 levels had a sensitivity of 87.5% and specificity of 67.7% for predicting SAP, comparable to the Ranson score in some aspects.
  • Disease Severity Correlation: Card9 levels were positively correlated with SAP severity and decreased as symptoms alleviated.

Limitations and Future Work

  • Sample Size for ROC: While the ROC analysis is promising, the authors note that the number of SAP patients (n=17) was limited, suggesting that a larger cohort would be beneficial for further validation.
  • Mechanism of Aseptic Activation: The precise endogenous triggers that activate Card9 in aseptic SAP remain to be fully elucidated. The paper proposes possibilities like exogenous macromolecules or the release of heparan sulphate, but further investigation is needed.
  • Therapeutic Interventions: The study highlights Card9 as a potential therapeutic target, but direct therapeutic interventions targeting Card9 in aseptic SAP were not explored. Future work could focus on developing and testing such interventions.
  • Rat Model: The authors suggest using a rat model to further investigate the molecular mechanisms of the Card9-Bcl10 complex in SAP, particularly in the context of aseptic inflammation.
  • Broader Spectrum of SAP: The study focused on aseptic SAP. Future research could explore Card9's role in infectious SAP and compare its mechanisms across different etiologies.

Summary updated

Abstract

Activated mononuclear cells are an early event in the course of severe acute pancreatitis (SAP). To date, the molecular mechanism triggering peripheral blood mononuclear cells (PBMCs) is poorly understood. The aim of this paper was to determine the potential role of Card9 in SAP. We collected data from 72 subjects between January 2013 and June 2014. Subsequently, PBMCs were isolated on day 1, 3 and 5 of pancreatitis. Immunofluorescence staining, quantitative real-time PCR, Western blotting, immunoprecipitation and ELISA were used to determine the role of Card9 in SAP. Microbial culture showed that SAP patients at the early period did not develop any bacteria and fungi infection. Card9 expression in SAP patients was higher than that in mild acute pancreatitis and volunteer healthy controls, up to the peak on day 1. The monocyte-derived cytokines interleukin (IL)-17, IL-1β, IL-6 and tumour necrosis factor-α mediated by the induction of Card9 markedly increased in SAP patients compared with the control group. Furthermore, the inducible formation of Card9-Bcl10 complex was found in PBMCs, which may be involved in nuclear factor kappa B (NF-κB) and p38 activation in SAP. Receiver operating characteristic curve indicated that Card9 levels had a high sensitivity of 87.5% and specificity of 67.7%, showing the close correlation with SAP patients. Card9 overexpression was firstly found in aseptic SAP, which may be played an important role in NF-κB and p38 activation in PBMCs. It also provided the new insights into therapeutic interventions by targeting monocytes activation in SAP patients.
BibTeX
@article{yang2015role,
  author = {Zhi‐wen Yang and Chengzhao Weng and Jing Wang and Ping Xu},
  title = {{The role of Card9 overexpression in peripheral blood mononuclear cells from patients with aseptic acute pancreatitis}},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2015},
  doi = {10.1111/jcmm.12738},
}
Figure